Siren, L.L.C. Lexicon Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $2.56 Trillion
- Q3 2025
A detailed history of Siren, L.L.C. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 38,918,903 shares of LXRX stock, worth $55.3 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
38,918,903
Previous 38,918,903
-0.0%
Holding current value
$55.3 Million
Previous $36.8 Billion
42.75%
% of portfolio
2.06%
Previous 1.9%
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
227MCall Options Held
2.5MPut Options Held
271K-
Artal Group S.A. Luxembourg, N4136MShares$193 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.52MShares$13.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.83MShares$5.44 Million0.0% of portfolio
-
Sessa Capital Im, L.P. New York, NY3MShares$4.26 Million0.1% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $268M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...